World Conference on Cancer Research and Novel Drug Development

Dear Esteemed Participants,
The World Conference on Cancer Research and Novel Drug Development (WCCRDD-2027), scheduled for September 13-15, 2027, in Tokyo, Japan. will serve as a premier platform for oncologists, researchers, pharmaceutical experts, and healthcare professionals to explore the latest advancements in cancer treatment and drug discovery. The conference will cover a wide range of topics, including cancer biology, precision medicine, immunotherapy, targeted drug development, and emerging technologies such as AI-driven oncology and nanomedicine. Discussions will also focus on advancements in clinical trials, biomarker discovery, and innovative screening techniques to improve early detection and patient outcomes. Through keynote presentations, panel discussions, workshops, and networking sessions, the summit aims to foster interdisciplinary collaboration and accelerate breakthroughs in cancer therapeutics. By bringing together experts from academia, industry, and healthcare, WCCRDD-2027 will play a crucial role in shaping the future of oncology and revolutionizing cancer treatment strategies worldwide.
Welcome To WCCRDD-2027!

Precision Medicine and Genomics in Oncology Predictive and Prognostic Biomarkers in Cancer Overcoming Drug Resistance in Cancer Therapy Organoid and 3D Tissue Models for Cancer Research

Tumor Microenvironment and Cancer Progression
Genetic and Epigenetic Alterations in Cancer
Cancer Stem Cells and Metastasis
Role of Inflammation and Immunity in Cancer Development
Advances in Immunotherapy and Checkpoint Inhibitors
CAR-T Cell Therapy and Personalized Immunotherapy
Neoantigen-Based Cancer Vaccines
Precision Medicine and Genomics in Oncology
Predictive and Prognostic Biomarkers in Cancer
Artificial Intelligence in Cancer Diagnostics and Treatment
Targeted Therapies and Small-Molecule Inhibitors
RNA-Based Therapies and Gene Editing in Cancer Treatment
Overcoming Drug Resistance in Cancer Therapy
AI-Driven Drug Discovery and Repurposing Strategies
Tumor Heterogeneity and Its Impact on Treatment
Liquid Biopsy and Non-Invasive Diagnostic Tools